Biopharmaceutical company to unify quality management on a single platform BARCELONA, Spain \u2014 4 Sep, 2019<\/strong> \u2014 Veeva Systems<\/a> (NYSE:VEEV) today announced that Alvotech selected Veeva QMS<\/a> to streamline quality processes across the organization with improved efficiency and compliance. Alvotech\u2019s adoption of Vault QMS builds upon the company\u2019s success with Veeva Vault QualityDocs<\/a> for document management and control. <\/p>\n Alvotech required an easy to use system that would eliminate manual processes and support compliance. With Veeva Vault Quality Suite, Alvotech can reduce overhead while providing visibility into quality processes across the organization. As a fast-growing business, Alvotech also chose Vault Quality Suite for greater agility and scalability to meet changing needs of the business. <\/p>\n \u201cAs a company on the forefront of manufacturing technology, Alvotech is committed to maintaining its cutting-edge approach towards how we manage our quality systems,\u201d said Jonas B. Hauksson, senior director of quality management at Alvotech. \u201cUnifying quality processes on a single cloud platform will replace manual operations with modernized systems that are easy to use and flexible.\u201d<\/p>\n \u201cAlvotech is a great example of how organizations are modernizing critical business functions like quality,” said Robert Gaertner, director of strategy for Vault Quality at Veeva. “Veeva is proud to team with Alvotech to unify their quality processes and create the foundation for a harmonized quality system.\u201d <\/p>\n Vault Quality Suite helps streamline business processes and content across global sites, suppliers, contract manufacturers, and other partners to speed workflows for greater efficiency.<\/p>\n Learn how Vault Quality Suite is enabling organizations to modernize quality management at the upcoming Veeva R&D Summit Europe<\/a>, 19-20 May 2020. The event is open to Veeva customers and invited guests. Register and view the agenda at veeva.com\/eu\/rd-summit\/<\/a>.<\/p>\n Additional Information<\/strong> About Veeva Systems<\/strong> Forward-looking Statements<\/strong> ###<\/p>\n
\nfor greater efficiency and compliance<\/em><\/p>\n
\nFor more on Veeva Vault Quality Suite, visit: veeva.com\/eu\/quality<\/a>
\nConnect with Veeva on LinkedIn: linkedin.com\/company\/veeva-systems<\/a>
\nFollow @veeva_eu on Twitter: twitter.com\/veevasystems<\/a>
\nLike Veeva on Facebook: facebook.com\/veevasystems<\/a><\/p>\n
\nVeeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 675 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. For more information, visit veeva.com\/eu<\/a>.<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of Veeva\u2019s products and services, the results from use of Veeva\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-Q for the period ended October 31, 2018. This is available on the company\u2019s website at veeva.com<\/a> under the Investors section and on the SEC\u2019s website at sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.<\/p>\n